EFFICACY OF RIFAXIMIN IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D) AND PRIOR USE OF IBS MEDICATIONS

被引：0
|
作者：
Lembo, Anthony J.
Rao, Satish S.
Rezaie, Ali
Heimanson, Zeev
Pimentel, Mark
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1194
引用
收藏
页码：S499 / S499
页数：1
相关论文
共 50 条
  • [1] Responders Analysis in Patients With Diarrhea-Predominant Irritable Bowel Syndrome IBS-D) Treated With Rifaximin
    Lembo, Anthony J.
    Heimanson, Zeev
    Pimentel, Mark
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S236 - S236
  • [2] Stool microbiota characterization in patients with diarrhea-predominant irritable bowel syndrome (IBS-D) receiving repeat Rifaximin
    Pimentel, M.
    Fodor, A. A.
    Golden, P. L.
    Bortey, E.
    Forbes, W. P.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 28 : 100 - 100
  • [3] Analysis of Potential Predictors of Symptom Recurrence in Patients Treated with Rifaximin for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
    Lembo, Anthony J.
    Rao, Satish
    Wolf, Ray
    Pimentel, Mark
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S253 - S253
  • [4] Efficacy of Rifaximin on Bowel Movement Urgency in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D): A Pooled Analysis of 3 Phase 3 Trials
    Pimentel, Mark
    Cash, Brooks D.
    Wolf, Ray
    Lembo, Anthony J.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S253 - S254
  • [5] Improvements over Time in Individual Diarrhea-Predominant Irritable Bowel Syndrome Symptoms (IBS-D) with Rifaximin Repeat Treatment
    Pimentel, Mark
    Lembo, Anthony J.
    Wolf, Ray
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S240 - S240
  • [6] Infection-Related Safety Profile of Rifaximin Repeat Treatment for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
    Chey, William D.
    Lembo, Anthony J.
    Wolf, Ray A.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S750 - S751
  • [7] RIFAXIMIN REPEAT TREATMENT FOR DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D) AND IMPACT ON CLOSTRIDIUM DIFFICILE INFECTION DEVELOPMENT
    Pimentel, Mark
    Schoenfeld, Phillip
    Heimanson, Zeev
    Cash, Brooks D.
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S499 - S500
  • [8] RIFAXIMIN IS EFFICACIOUS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) IN ADULTS PREVIOUSLY TREATED WITH OTHER IBS MEDICATIONS
    Rao, Satish S.
    Schoenfeld, Philip S.
    Heimanson, Zeev
    Rezaie, Ali
    Lacy, Brian E.
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S852 - S852
  • [9] Spotlight: Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D)
    Smalley, Walter
    Falck-Ytter, Corinna
    Carrasco-Labra, Alonso
    Wani, Sachin
    Lytvyn, Lyubov
    Falck-Ytter, Yngve
    [J]. GASTROENTEROLOGY, 2019, 157 (03) : 858 - 858
  • [10] Psychosocial determinants of rifaximin adherence for the treatment of diarrhea-predominant irritable bowel syndrome (IBS)
    Sherwin, L.
    Krisanabud, P.
    Deroche, C.
    Matteson-Kome, M.
    Ruppar, T.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 30
12345